Sionna Therapeutics, Inc. (SION) earnings

SION earnings moved a median of +3.61% by the close. Quarterly and annual SION reports and results, each read against the price at its own news timestamp. Back to the SION overview →

14 measured SION earnings events.

Where these SION earnings landedvs 14 measured SION earnings reactions
SION earningsMiddle 50% · -1.32% to +5.84%Zero: 0.00%Median: +3.61%Median +3.61%-8.00%0+8.00%
Middle 50% of SION earnings reactions-1.32% to +5.84%
Median reaction (to close)+3.61%
Measured reactions14
Point-in-time · zero look-ahead

Half of the 14 SION earnings events with a measured close landed between -1.32% and +5.84%; 64% closed up.

DateHeadlineEvent5-minTo close
Form 10-Q Sionna Therapeutics, For: Sep 30SEC filing · Form 10-Q-1.15%+6.02%
Sionna Therapeutics Reports Third Quarter 2026 Financial ResultsPress release-1.15%+6.02%
Form 10-Q Sionna Therapeutics, For: Jun 30SEC filing · Form 10-Q+1.20%+5.31%
Sionna Therapeutics Reports Second Quarter 2026 Financial ResultsPress release+1.20%+5.31%
Form 10-Q Sionna Therapeutics, For: Mar 31SEC filing · Form 10-Q-5.04%-9.16%
Sionna Therapeutics Reports First Quarter 2026 Financial ResultsPress release-5.04%-9.16%
Form 10-K Sionna Therapeutics, For: Dec 31SEC filing · Form 10-K+5.25%+3.13%
Form 10-Q Sionna Therapeutics, For: Sep 30SEC filing · Form 10-Q+0.00%-1.32%
Sionna Therapeutics Reports Third Quarter 2025 Financial ResultsPress release+0.00%-1.32%
Form 10-Q Sionna Therapeutics, For: Jun 30SEC filing · Form 10-Q-3.92%+7.63%
Sionna Therapeutics Reports Second Quarter 2025 Financial ResultsPress release-3.92%+7.63%
Form 10-Q Sionna Therapeutics, For: Mar 31SEC filing · Form 10-Q+2.05%+3.61%
Sionna Therapeutics Reports First Quarter 2025 Financial ResultsPress release+2.05%+3.61%
Form 10-K Sionna Therapeutics, For: Dec 31SEC filing · Form 10-K-1.62%-2.12%
That’s how SION usually reacts to earnings — get an email when it moves on news →
Keep exploring

More SION: analyst actions → · SEC filings → · SION overview →